Kosuke Imamura

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies

Ryo Sato, Kosuke Imamura, Shinya Sakata et al. · Journal of Clinical Medicine · 2019 · 89 citations · Full text

Life Sciences, Immunology, Oncology +17

<i>Clostridium butyricum</i> therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors

Yusuke Tomita, Yoshihiko Goto, Shinya Sakata et al. · OncoImmunology · 2022 · 89 citations · Full text

Life Sciences, Microbiology, Oncology +17

Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events

Hirotake Tsukamoto, Yoshihiro Komohara, Yusuke Tomita et al. · Proceedings of the National Academy of Sciences · 2022 · 71 citations · Full text

Medicine, Immunology, Oncology +17

TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung Adenocarcinoma

Ryo Sato, Kosuke Imamura, Takashi Semba et al. · Cancer Research · 2021 · 67 citations · Full text

Medicine, Oncology, Pathology +17

Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations

Yusuke Tomita, Shinya Sakata, Kosuke Imamura et al. · Cancers · 2023 · 31 citations · Full text

Life Sciences, Immunology, Oncology +17